Gunderson Health System

La Crosse, Wisconsin 54601-5467

1 studies enrolling now · 8 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, CLL, Cancer, Cancer Metastatic, Chronic Lymphocytic Leukemia, Coronary Artery Disease, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Retinopathy, GERD, Gastroesophageal Reflux Disease

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• The Impact of Diabetes on REvascularization — Completed
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
• LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy — Completed
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early